JUNSHI BIO (01877): The Strategic Committee is adjusted to the Strategic and ESG Committee.
Jinshi Biology (01877) announced that in order to further enhance the company's environmental, social, and corporate governance (ESG) management level and strengthen the company's sustainable development capabilities, in accordance with relevant laws and the company's articles of association, and based on the company's actual situation, the board of directors has decided to adjust the original strategic committee to the strategic and ESG committee, effective from March 13, 2026. The original "Regulations of the Strategic Committee" will be adjusted to the "Regulations of the Strategic and ESG Committee," adding responsibilities such as ESG management on the basis of the original authority.
JUNSHI BIO (01877) Announcement: In order to further enhance the company's environmental, social, and corporate governance (ESG) management capabilities, strengthen the company's sustainable development capabilities, and in accordance with relevant laws and the company's articles of association, taking into account the actual situation of the company, the Board of Directors has resolved to adjust the former Strategic Committee to the Strategic and ESG Committee, effective from March 13, 2026. The former "Strategic Committee working rules" will be adjusted to the "Strategic and ESG Committee working rules", with additional responsibilities in ESG management based on the original authority.
The Strategic and ESG Committee is mainly responsible for researching the company's long-term development strategy, significant investment decisions, sustainable development, and ESG, and providing recommendations to the Board of Directors. This adjustment only pertains to the name and responsibilities of the committee, with no changes to its composition, term limits, etc.
Related Articles

HELENS (09869) announced good news of profit, with expected shareholders' net profit for the year 2025 to be approximately 15 million to 45 million yuan, reversing losses to profits compared to the previous year.

CIRCUTECH (08051) released its annual performance with a net profit attributable to shareholders of HK$8.147 million.

MINIMAX-WP(00100): Approval from the Hong Kong Stock Exchange for the company to be a commercialized company.
HELENS (09869) announced good news of profit, with expected shareholders' net profit for the year 2025 to be approximately 15 million to 45 million yuan, reversing losses to profits compared to the previous year.

CIRCUTECH (08051) released its annual performance with a net profit attributable to shareholders of HK$8.147 million.

MINIMAX-WP(00100): Approval from the Hong Kong Stock Exchange for the company to be a commercialized company.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


